bonefos 60mg/ml solution for infusion iv
bayer phils inc - disodiuim clodronate (as tetrahydrate) - solution for infusion iv - 60mg/ml
loron 400mg capsules
roche products ltd - sodium clodronate - oral capsule - 400mg
bonefos concentrate 300mg/5ml solution for infusion ampoules
bayer plc - sodium clodronate - solution for infusion - 60mg/1ml
milk of magnesia traditional mint flavoured liquid, 415 mg/5 ml, oral suspension
chefaro ireland dac - magnesium hydroxide - oral suspension - 415 mg/5ml - magnesium compounds; magnesium hydroxide
pamidronate disodium teva 3mg/ml concentrate for s
teva pharmaceuticals europe b.v. - pamidronic acid - concentrate for soln for inf - 3 mg/ml
aclasta
novartis pharmaceuticals australia pty ltd - zoledronic acid monohydrate -
pamisol injection
hospira australia pty ltd - disodium pamidronate -
aclasta
sandoz new zealand limited - zoledronic acid monohydrate 0.0533 mg/ml equivalent to zoledronic acid 0.05 mg/ml - solution for infusion - 5 mg/100ml - active: zoledronic acid monohydrate 0.0533 mg/ml equivalent to zoledronic acid 0.05 mg/ml excipient: mannitol sodium citrate dihydrate water for injection - · treatment of osteoporosis in postmenopausal women to reduce the incidence of hip, vertebral and non-vertebral fractures and to increase bone mineral density. · prevention of postmenopausal osteoporosis.
bonefos injection (pom)
disodium clodronate 60mg/ml
bonefos tablets (pom)
sodium clodronate 800mg